You have 9 free searches left this month | for more free features.

blood stem cells

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Saint Louis (vosaroxin, Azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 23, 2022

Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

Withdrawn
  • Leukemia
  • Stem Cell Transplantation
  • Munich, Bavaria, Germany
    3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Brain and CNS Tumors Trial in Los Angeles (therapeutic autologous dendritic cells)

Completed
  • Brain and Central Nervous System Tumors
  • therapeutic autologous dendritic cells
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

AML, Adult Trial in Italy (IDH mutation test performed at diagnosis or relapse until January 31st, 2019.)

Completed
  • AML, Adult
  • IDH mutation test performed at diagnosis or relapse until January 31st, 2019.
  • Alessandria, Italy
  • +23 more
Dec 31, 2021

Metabolism of Prostaglandin D2 Trial in Nashville (dietary supplement, drug, other)

Enrolling by invitation
  • Metabolism of Prostaglandin D2
  • niacin
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University
Jan 25, 2022

Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

Recruiting
  • Anaplastic Large Cell Lymphoma
  • +19 more
  • Duarte, California
  • +2 more
Aug 15, 2022

Covid19, type1diabetes Trial in Esbjerg

Recruiting
  • Covid19
  • type1diabetes
    • Esbjerg, Denmark
      Hospital of South West Jutland
    Mar 16, 2022

    Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

    Terminated
    • Prostate Cancer
    • San Francisco, California
    • +4 more
    Jan 30, 2023

    Coagulopathy in Acute Aortic Syndrome

    Recruiting
    • Coagulopathy
      • Paris, France
        Université de Paris
      Nov 25, 2021

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic

      Terminated
      • Recurrent B Acute Lymphoblastic Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 28, 2022

      Hepatocellular Carcinoma Trial in Nanjing (hypovolemic phlebotomy)

      Recruiting
      • Hepatocellular Carcinoma
      • hypovolemic phlebotomy
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital of Nanjing Medical University
      Jun 1, 2023

      Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)

      Active, not recruiting
      • Cold Urticaria
      • +4 more
      • Berlin, Germany
        Charite University
      Dec 20, 2022

      Lung Cancer, Thoracic Surgery, Video-Assisted, Lobectomy Trial in Heerlen (Preoperative 3D lung reconstruction created with

      Completed
      • Lung Cancer
      • +5 more
      • Preoperative 3D lung reconstruction created with open-source software
      • Heerlen, Limburg, Netherlands
        Zuyderland Medical Center
      Nov 9, 2023

      Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)

      Recruiting
      • Sickle Cell Disease
      • Etavopivat Tablets Low dose
      • +3 more
      • Birmingham, Alabama
      • +77 more
      Oct 11, 2022

      Crohn Disease, Ulcerative Colitis Trial (Adalimumab-680LT, Control)

      Not yet recruiting
      • Crohn Disease
      • Ulcerative Colitis
      • (no location specified)
      Oct 30, 2023

      Hidradenitis Suppurativa (HS) Trial in Lyon (Skin Swab & Skin Biopsies & Blood Sample)

      Not yet recruiting
      • Hidradenitis Suppurativa (HS)
      • Skin Swab & Skin Biopsies & Blood Sample
      • Lyon, Rhône, France
        Department of Dermatology-Hôpital Edouard Herriot
      Feb 9, 2023

      Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

      Active, not recruiting
      • Fallopian Tube Clear Cell Adenocarcinoma
      • +26 more
      • Clinical Observation
      • +4 more
      • Birmingham, Alabama
      • +314 more
      Sep 28, 2021

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Terminated
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      Mar 28, 2022

      Samples From People With Unanticipated Response, Significant

      Enrolling by invitation
      • Cancer
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 24, 2022

        Arthritis, Rheumatoid Trial in Worldwide (CE-224,535, Placebo)

        Completed
        • Arthritis, Rheumatoid
        • Mesa, Arizona
        • +26 more
        Mar 9, 2022

        C3PI Study Testing Group Trial in Kannapolis (Tasso-SST on Demand, Regular Phlebotomy)

        Completed
        • C3PI Study Testing Group
        • Tasso-SST on Demand
        • Regular Phlebotomy
        • Kannapolis, North Carolina
          Duke CTSI Translational Population Health Office
        Jul 5, 2022

        Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))

        Active, not recruiting
        • Multiple Sclerosis
        • 7-day Fasting-Mimicking Diet (7-DAY FMD)
        • Genova, Italy
          Ospedale San Martino
        Sep 8, 2023

        HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou

        Recruiting
        • HIV Infection
        • Combined Antiretroviral Therapy
          • Hangzhou, Zhejiang, China
            Zhikai Wan
          Aug 30, 2023

          Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex)

          Completed
          • Glioblastoma
          • Los Angeles, California
          • +3 more
          Sep 21, 2021